Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

---

Increasing the average age of the population as well as sports injuries, bone-related diseases, such as osteoporosis, rupture or damage to cartilage and bone tissues, and bone fractures, has dramatically increased the need for repair and joint replacement surgeries. Biocompatible materials that are used as prosthetic stabilizers and bone fillers in orthopedic surgery are known as injectable bone cement (IBCs). Available clinical IBCs, such as polymethyl methacrylate and calcium phosphate cement are the most important of these materials. This paper presents the most popular substances for medical use. Although this replacement procedure reduces the pain and restores joint function, it is associated with several drawbacks that limit its efficiency and effectiveness, and sometimes patients should undergo revision surgeries. Recently, the development of the next generation of IBCs, which are bioactive and degradable with good mechanical properties, is of great interest. For the long-term clinical performance in cement arthroplasty, the next generation of bone cement with far greater mechanical and biological properties than acrylic bone cement on the market is required. As a result, new approaches and formulas have been developed using various techniques from different disciplines. This study summarizes the challenges, developments, and recommendations for the future. For this purpose, various literature from databases, such as ScienceDirect, SpringerLink, PubMed, and so on were consulted from 2000 to 2020.

Keywords: Bone tissue engineering, Bone cement, Polymethylmethacrylate (PMMA), Tri-calcium phosphate (TCP), Setting characteristics, Modification, Filling materials, Nanostructured materials

Full-Text [PDF 2131 kb]   (778 Downloads) |   |   Full-Text (HTML)  (784 Views)  

Add your comments about this article : Your username or Email:

---